|
ZNF195 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.224800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.115500E-02 |
| Normal-vs-Stage2 |
6.354100E-02 |
| Normal-vs-Stage3 |
2.292200E-01 |
| Normal-vs-Stage4 |
2.702000E-01 |
| Stage1-vs-Stage2 |
1.988160E-01 |
| Stage1-vs-Stage3 |
7.892600E-01 |
| Stage1-vs-Stage4 |
4.123800E-01 |
| Stage2-vs-Stage3 |
2.834400E-01 |
| Stage2-vs-Stage4 |
6.982800E-01 |
| Stage3-vs-Stage4 |
6.424800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.626130E-02 |
| Normal-vs-AfricanAmerican |
4.765800E-02 |
| Normal-vs-Asian |
1.607410E-01 |
| Caucasian-vs-AfricanAmerican |
6.487400E-01 |
| Caucasian-vs-Asian |
2.192200E-01 |
| AfricanAmerican-vs-Asian |
3.869800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.765810E-02 |
| Normal-vs-Female |
2.808400E-02 |
| Male-vs-Female |
6.028400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.289800E-02 |
| Normal-vs-Extreme_Weight |
2.233400E-01 |
| Normal-vs-Obese |
2.268200E-02 |
| Normal-vs-Extreme_Obese |
3.969000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.985600E-01 |
| Normal_Weight-vs-Obese |
7.943400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.241600E-01 |
| Extreme_Weight-vs-Obese |
2.019000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.881800E-01 |
| Obese-vs-Extreme_Obese |
5.234600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.565580E-02 |
| Normal-vs-Age(41-60Yrs) |
1.341180E-03 |
| Normal-vs-Age(61-80Yrs) |
1.300650E-01 |
| Normal-vs-Age(81-100Yrs) |
7.697800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.024400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.264840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.332000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.260300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.944400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.659200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.035900E-02 |
| Normal-VS-Type2 PRCC |
9.009700E-02 |
| Normal-VS-KIRP CIMP |
5.176000E-01 |
| Normal-VS-Unclassified PRCC |
1.255780E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.717800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.285990E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.837200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.623600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.999800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.908030E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.472590E-01 |
| Normal-vs-N1 |
2.125800E-02 |
| Normal-vs-N2 |
3.749800E-02 |
| N0-vs-N1 |
1.349960E-01 |
| N0-vs-N2 |
7.078000E-02 |
| N1-vs-N2 |
6.092200E-02 |
|
|
